Epilepsy is a common chronic neurological disorder characterized by recurrent unprovoked seizures. These seizures are transient signs and/or symptoms of abnormal, excessive or synchronous neuronal activity in the brain. About 50 million people worldwide have epilepsy, with almost 90% of these people being in developing countries.
|
[News]
Epilepsy Surgery Can Have Beneficial Effect on Memory
Patients with drug-resistant epilepsy run the risk of gradual deterioration in their cognitive abilities. Surgical treatment generally puts an end to seizures but can have a negative effect on memory. However, there is no further deterioration in memory, and some patients may even recover some of their memory capacity, reveals a thesis from the University of Gothenburg.
|
|
[News]
What Causes Seizure in Focal Epilepsy?
what are the earliest cellular events leading to the initiation of a focal seizure? Elucidating this issue is of paramount importance both for understanding the pathophysiology of focal epilepsies and for the development of new pharmacological strategies for drug-resistant forms of these disorders.
|
|
[News]
Studying Altered Brain Cells Sheds Light on Epilepsy
Neuroscience researchers have zeroed in on a novel mechanism that helps control the firing of electrical signals among neurons. By isolating the molecular and electrical events that occur when this control is disrupted, the new research sheds light on epileptic seizures and potentially on other prominent diseases involving poorly regulated brain activity.
|
|
[News]
FDA Panel Recommends Therapy For Patients With Refractory Epilepsy
The U.S. Food and Drug Administration (FDA) Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain Stimulation (DBS) Therapy for Epilepsy from Medtronic, Inc. (NYSE: MDT) as adjunctive treatment for partial-onset seizures in adults with medically refractory epilepsy.
|
|
|
|
|
[